Related Experiment Video
Updated: Aug 30, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP
Manuel Tancer1, Chris-Ellyn Johanson
1Department of Psychiatry and Behavioral Neurosciences, Substance Abuse Research Division, Addiction Research Institute, Wayne State University, 2761 E Jefferson, Detroit, MI 48207, USA. mtancer@med.wayne.edu
Abstract:
3,4-methylenedioxymethamphetamine (MDMA) is a widely used drug of abuse chemically related to both the amphetamines and mescaline. Laboratory animal studies have shown that MDMA is a potent re-uptake inhibitor and releaser of dopamine and serotonin. Although the subjective and physiological effects of MDMA have been compared to d-amphetamine in humans, no direct comparison with a serotonin releasing agent has been reported and reinforcing effects have not been evaluated. In this paper we report a direct comparison of the reinforcing, subjective, and physiological effects of MDMA (1 and 2 mg/kg) to d-amphetamine (10 and 20 mg), to metachlorophenylpiperazine (mCPP--a serotonin releasing agent (0.5 and 0.75 mg/kg)), and to placebo using a within-subject design in 12 volunteers with moderate MDMA experience. Both the high dose of d-amphetamine and MDMA showed significant reinforcing effects as indicated by high cross-over values on the multiple choice procedure compared to all other treatments. All three drugs showed dose-dependent changes in subjective effects whereas physiological effects were most pronounced for MDMA with almost no changes seen with mCPP. The subjective effects of MDMA were similar both to those of mCPP and d-amphetamine, suggesting that both dopamine and serotonin systems are involved in mediating these effects. In contrast, only the dopaminergic agents, d-amphetamine and MDMA, had reinforcing effects.
Insights
3,4-methylenedioxymethamphetamine (MDMA) and d-amphetamine exhibit reinforcing effects, unlike the serotonin agent mCPP. MDMA
Area of Science:
- Neuroscience
- Psychopharmacology
- Addiction Research
Background:
- 3,4-methylenedioxymethamphetamine (MDMA) is a recreational drug with amphetamine and mescaline similarities.
- Animal studies indicate MDMA affects dopamine and serotonin systems.
- Human studies lack direct comparisons of MDMA's reinforcing effects with serotonin agents.
Purpose of the Study:
- To directly compare the reinforcing, subjective, and physiological effects of MDMA.
- To compare MDMA against d-amphetamine and mCPP (a serotonin releasing agent).
- To evaluate these effects in human volunteers.
Main Methods:
- A within-subject design was used with 12 volunteers.
- Drugs administered included MDMA, d-amphetamine, mCPP, and placebo.
- Reinforcing effects were assessed using a multiple choice procedure.
Main Results:
- Both high-dose d-amphetamine and MDMA demonstrated significant reinforcing effects.
- MDMA and d-amphetamine showed dose-dependent subjective effects.
- Physiological effects were most prominent with MDMA; mCPP had minimal impact.
Conclusions:
- Dopamine and serotonin systems likely mediate MDMA's subjective effects.
- Reinforcing effects are primarily associated with dopaminergic agents like d-amphetamine and MDMA.
- MDMA's reinforcing properties distinguish it from the serotonin-specific agent mCPP.
Related Concept Videos
CNS Stimulants: Psychedelic Agents
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drug Abuse and Addiction: Pharmacological Phenomena

